Suppr超能文献

经尿道球周植入、翻修和更换人工尿道括约肌在神经源性和非神经源性男性患者中的应用:一年经验的初步可行性研究。

Ambulatory peri-bulbar implantation, revision and replacement of Artificial Urinary Sphincter in neurogenic and non-neurogenic male patients: A preliminary feasibility study over a one-year experience.

机构信息

Department of Urology, University of Verona, Piazzale Aristide Stefani, 1, 37126 Verona (VR), Italy; Department of Urology, Pitié-Salpêtrière Hospital, 47-83 Boulevard de l'Hôpital, 75013 Paris, France.

Department of Urology, Pitié-Salpêtrière Hospital, 47-83 Boulevard de l'Hôpital, 75013 Paris, France.

出版信息

Prog Urol. 2023 Jul;33(7):377-383. doi: 10.1016/j.purol.2023.02.005. Epub 2023 Mar 14.

Abstract

INTRODUCTION

Our goal was to determine the rate of complications, early revision and removal after full ambulatory implantation of bulbar AUS in men; secondly, to describe satisfaction and short-term continence rate.

MATERIAL AND METHODS

Between April 2018 and April 2019, 28 consecutive patients underwent AUS implantation in a newly organised ambulatory setting. A prospective database of all included patients was established with comprehensive data collected on medical history, aetiology and severity of SUI, surgical procedures, postoperative complications and patient satisfaction.

RESULTS

Twenty-eight patients were included (30 consecutive procedures: 22 primary AUS placement, 6 complete revisions, 2 partial revisions), with a mean follow up of 223±220.5 days. Fourteen patients had prior radiotherapy. Readmission rate was 6.7% in the first 30 days after surgery. Both revision and removal rates were 6.7%. Complications were reported in 26.7% of procedures, mainly Clavien-Dindo I. Patient satisfaction of ambulatory surgery organisation and experience was high (87/5% satisfied or very satisfied). Full continence & social continence were achieved for, respectively, 55.6% and 88.9% of procedures.

CONCLUSION

Ambulatory placement of AUS is safe and can be performed successfully. Larger patient cohorts and randomised trials are crucial to improve knowledge on non-indications for full ambulatory AUS implantation in men.

摘要

简介

我们的目标是确定男性经全面门诊植入球海绵体肌刺激器(AUS)后的并发症发生率、早期翻修率和移除率;其次,描述满意度和短期控尿率。

材料与方法

2018 年 4 月至 2019 年 4 月,28 例连续患者在新组织的门诊环境中接受 AUS 植入。为所有纳入患者建立了一个前瞻性数据库,收集了全面的病史、SUI 的病因和严重程度、手术程序、术后并发症和患者满意度等数据。

结果

28 例患者入选(30 例连续手术:22 例初次 AUS 植入、6 例完全翻修、2 例部分翻修),平均随访 223±220.5 天。14 例患者曾接受过放疗。术后 30 天内再入院率为 6.7%。翻修和移除率均为 6.7%。26.7%的手术报告了并发症,主要为 Clavien-Dindo I 级。对门诊手术组织和体验的满意度很高(87/5%的患者满意或非常满意)。分别有 55.6%和 88.9%的手术达到完全控尿和社交控尿。

结论

AUS 的门诊植入是安全的,并且可以成功进行。更大的患者队列和随机试验对于提高男性非全门诊 AUS 植入适应证的知识至关重要。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验